Lei Shi
Impact in
- Infectious Diseases top 0.05%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 1%
- Mesenchymal stem cell research
Papers in
- Genetics 19
- Mesenchymal stem cell research 19
-
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 and COVID-19 Research 8
- Co-authors
- Fu‐Sheng Wang (10 shared papers)Chao Zhang (4 shared papers)Zhe Xu (4 shared papers)Jinghui Dong (1 shared paper)Lei Huang (2 shared papers)Hongxia Liu (1 shared paper)Jin‐Wen Song (1 shared paper)Yanhong Tai (1 shared paper)
- Journals
- Stem Cell Research & Therapy (6 papers)Signal Transduction and Targeted Therapy (4 papers)Scientific Reports (3 papers)PLoS ONE (3 papers)American Journal of Respiratory Cell and Molecular Biology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lei Shi
128 papers receiving 16.6k citations
Lei Shi's Hit Papers
Peers
Comparison fields: 5 of 173
- Infectious Diseases 8.9k
- Genetics 872
- General Dentistry 32
- Neurology 844
- Cancer Research 735
Countries citing papers authored by Lei Shi
This map shows the geographic impact of Lei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Shi more than expected).
Fields of papers citing papers by Lei Shi
This network shows the impact of papers produced by Lei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Shi. The network helps show where Lei Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathological findings of COVID-19 associated with acute respiratory distress syndrome Hit paper breakdown → | 2020 | 6653 |
| 2 | Liver injury in COVID-19: management and challenges Hit paper breakdown → | 2020 | 1440 |
| 3 | A minimal common outcome measure set for COVID-19 clinical research Hit paper breakdown → | 2020 | 1287 |
| 4 | Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus Hit paper breakdown → | 2006 | 820 |
| 5 | ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia Hit paper breakdown → | 2005 | 698 |
| 6 | 2020 | 497 | |
| 7 | Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma Hit paper breakdown → | 2020 | 449 |
| 8 | 2009 | 278 | |
| 9 | 2020 | 258 | |
| 10 | 2020 | 235 | |
| 11 | 2020 | 230 | |
| 12 | 2021 | 220 | |
| 13 | 2021 | 215 | |
| 14 | 2020 | 200 | |
| 15 | 2015 | 198 | |
| 16 | 2016 | 158 | |
| 17 | 2010 | 132 | |
| 18 | 2021 | 132 | |
| 19 | 2022 | 129 | |
| 20 | 2005 | 127 |
About Lei Shi
Lei Shi is a scholar working on Genetics, Infectious Diseases, Cancer Research, Oncology and Otorhinolaryngology, having authored 132 papers that have together received 17.1k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (19 papers), COVID-19 Clinical Research Studies (18 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Head and Neck Cancer Studies (6 papers), MicroRNA in disease regulation (5 papers), Viral-associated cancers and disorders (4 papers), Optical Imaging and Spectroscopy Techniques (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Infectious Diseases (8.9k citations), Genetics (872 citations), General Dentistry (32 citations), Neurology (844 citations) and Cancer Research (735 citations). Lei Shi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Fu‐Sheng Wang, Chao Zhang, Zhe Xu, Jinghui Dong, Lei Huang, Hongxia Liu, Jin‐Wen Song, Yanhong Tai, Changqing Bai and Yijin Wang. Their work appears in journals such as Stem Cell Research & Therapy, Signal Transduction and Targeted Therapy, Scientific Reports, PLoS ONE and American Journal of Respiratory Cell and Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.